View Post

IU Precision Health Initiative has dramatic results for triple negative breast cancer patient

In Clinical Trials by Barbara Jacoby

By: Christine Drury From: iu.edu Five years ago, Jackie Stephens rolled over in bed and felt a horrible pain in her right breast. A subsequent mammogram revealed a large lump in her right breast and two smaller ones. Her diagnosis: triple negative breast cancer. Stephens’ oncologist prescribed a treatment regimen of chemotherapy, a lumpectomy and radiation. When her treatment was …

View Post

Harbor Branch Oceanographic Institute researches ‘promising’ triple-negative breast cancer treatment

In In The News by Barbara Jacoby

By: Meghan McRoberts From: wptv.com Researchers at FAU’s Harbor Branch Oceanographic Institute have been awarded a large grant to look into the chance that a chemical released by sea sponges in various oceans could treat an aggressive form of breast cancer. “I find it really, really promising,” said Associate Research Professor, Dr. Esther Guzman. She is leading the research project …

View Post

Investigators Slow Growth by Starving Triple-Negative Breast Cancer Cells

In Clinical Trials by Barbara Jacoby

By: Jennifer Nesse From: specialtypharmacytimes.com Investigators from the Brazilian Biosciences National Laboratory have developed a strategy for slowing the growth of triple-negative breast cancer (TNBC) that involves cutting cancerous cells off from vital food sources. The study, published in the Journal of Biological Chemistry, focused on TNBC tumors, which often lack estrogen progesterone receptors and human epidermal growth factor receptor …

View Post

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

In In The News by Barbara Jacoby

By: Alex Gardner From: medicalxpress.com New findings from researchers in the Perelman School of Medicine at the University of Pennsylvania provide clues about immune response of tumors in patients with BRCA 1/2-related breast cancers. The research, published in the journal Clinical Cancer Research, could shape treatment strategies and clinical trial design for these patients, who make up about two percent …

View Post

MIT CSAIL’s AI can predict the onset of breast cancer 5 years in advance

In In The News by Barbara Jacoby

By: Kyle Wiggers From: venturebeat.com Breast cancer is the second leading cancer-related cause of death among women in the U.S. It’s estimated that in 2015, 232,000 women were diagnosed with the disease and approximately 40,000 died from it. And while exams like mammography have come into wide practice — in 2014, over 39 million breast cancer screenings were performed in …

View Post

Mexican teen invents breast cancer detecting “EVA” bra, after mom’s two-time cancer survival

In In The News by Barbara Jacoby

From: ntd.com Julian Rios Cantu almost lost his mother to breast  cancer after a diagnosis in 2013, and the traumatic experience inspired him to develop a game-changing new invention. The 19-year-old Mexican student has invented a bra, alongside friend and business partner Antonio Torres, after witnessing their mother and grandmother respectively battle with breast cancer. But it’s not just any …

View Post

Israeli genetic research may lead to new treatments for breast cancer

In In The News by Barbara Jacoby

Source: Xinhua From: xinhuanet.com Israeli researchers have found that the malfunction of two key genes often causes cancer, which may lead to new treatments for breast cancer, the Weizmann Institute of Science reported Thursday. The two genes, LATS1 and LATS2, are on a chain of biochemical reactions called the “hippo pathway.” Defects in this pathway in humans often lead to …

View Post

New Companion Diagnostic Test Launched for Patients With Breast, Gastric Cancers

In In The News by Barbara Jacoby

By: Gina Columbus From: targetedonc.com A new VENTANA HER2 dual in situ hybridization (ISH) companion diagnostic assay has been launched by Roche to help identify HER2 amplification for patients with breast cancer and gastric cancer who could be eligible to receive trastuzumab (Herceptin). The VENTANA HER2 Dual ISH DNA Probe Cocktail assay is designed to identify patients who have HER2-positive breast or gastric …